
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Histone Deacetylase 1 (HDAC1) CRISPR/Cas9 KO Plasmid (r) | sc-437285 | 20 µg | $397.00 |
Histone deacetylase 1 (HDAC1) is a class I lysine deacetylase that removes acetyl groups from histone tails to promote chromatin compaction and transcriptional repression. In rat cells, HDAC1 functions within multiprotein corepressor complexes such as NuRD, Sin3, and CoREST, coordinating epigenetic control of gene expression programs that regulate cell-cycle progression, differentiation, and DNA damage responses. By reshaping chromatin accessibility, HDAC1 influences pathways linked to replication stress, checkpoint control, and lineage-specific transcriptional networks. Dysregulated HDAC1 activity and altered histone acetylation states are commonly studied in models of oncogenic transformation, neurodevelopmental phenotypes, and inflammatory signaling where epigenetic imbalance contributes to disease-relevant transcriptional changes.
Histone Deacetylase 1 (HDAC1) CRISPR/Cas9 KO Plasmid (r) is a pool of plasmids designed for targeted disruption of the gene in rat cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Histone Deacetylase 1 (HDAC1) protein expression.
This CRISPR knockout system enables efficient generation of -deficient cell models for investigation of Histone Deacetylase 1 (HDAC1) signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.